Genetic immunization against cervical carcinoma
An alphavirus vector system comprising nucleic acid of a human papilloma virus origin is disclosed. A method of treating or preventing cervical cancer is also disclosed. The method includes administering the alphavirus vector system and/or a cell comprising nucleic acid derived from human papilloma virus (HPV) to a subject. The alphavirus vector system or the cell may be administered as a vaccine.
1. An Semliki Forest Virus vector system comprising a nucleic acid molecule of human papilloma virus (HPV) origin, wherein said nucleic acid molecule encodes at least one antigenic polypeptide fragment of an E6 or an E7 protein of HPV.
2. The Semliki Forest Virus vector system of claim 1 , wherein said antigenic polypeptide fragment comprises an antigenic polypeptide fragment of protein E6 and an antigenic polypeptide fragment of protein E7.
3. The Semliki Forest Virus vector system of claim 1 , further comprising a translational enhancer element.
4. The Semliki Forest Virus vector system of claim 1 , further comprising a sequence encoding an auto-protease.
5. The Semliki Forest Virus vector system of claim 4 , wherein said auto-protease is of foot-and-mouth-disease virus origin.
6. The Semliki Forest Virus vector system of claim 1 , wherein comprising an alphavirus structural protein and an alphavirus non-structural protein encoded by at least two independent nucleic acid molecules.
7. The Semliki Forest Virus vector system of claim 1 , wherein said HPV comprises HPV16 or HPV18.
8. The Semliki Forest Virus vector system of claim 1 , wherein said nucleic acid molecule further encodes a cytokine or a functional fragment thereof.
9. The Semliki Forest Virus vector system of claim 8 , wherein said cytokine comprises Granulocyte-Macrophage Colony-Stimulating-Factor or IL12.
10. A cell comprising the Semliki Forest Virus vector system of claim 1 .
11. A medicament comprising the Semliki Forest Virus vector system of claim 1 .
12. A medicament comprising the cell of claim 10 .
13. A method for treating or preventing cervical cancer, said method comprising administering the Semliki Forest Virus vector system of claim 1 to a female subject.
14. A method for treating or preventing cervical cancer, said method comprising administering the cell of claim 10 to a female subject.
15. A method for treating or preventing cervical cancer, said method comprising administering the medicament of claim 11 to a female subject.
16. The method according to claim 13 , further comprising administering a cytokine or a functional fragment thereof to the female subject.
17. The Semliki Forest Virus vector system of claim 2 , further comprising a translational enhancer element.
18. The Semliki Forest Virus vector system of claim 2 , further comprising a sequence encoding an auto-protease.
19. The Semliki Forest Virus vector system of claim 18 , wherein said auto-protease is of foot-and-mouth-disease virus origin.
20. The Semliki Forest Virus vector system of claim 2 , wherein said Semliki Forest Virus vector system comprises an alphavirus structural protein and an alphavirus non-structural protein are encoded by at least two independent nucleic acid molecules.
21. The Semliki Forest Virus vector system of claim 2 , wherein said HPV comprises HPV16 or HPV18.
22. The Semliki Forest Virus vector system of claim 2 , wherein said nucleic acid molecule further encodes a cytokine or a functional fragment thereof.
23. The Semliki Forest Virus vector system of claim 22 , wherein said cytokine comprises Granulocyte-Macrophage Colony-Stimulating-Factor or IL 12.
24. A cell comprising the Semliki Forest Virus vector system of claim 2 .
25. A composition comprising the cell of claim 24 .
26. A composition comprising the Semliki Forest Virus vector system of claim 2 .
27. A method of treating or preventing cervical cancer, said method comprising administering the Semliki Forest Virus vector system of claim 2 to a subject in need thereof.
28. The method according to claim 27 , further comprising administering a cytokine to the subject.